257 related articles for article (PubMed ID: 21911581)
1. Perfusion-cultured bovine anterior segments as an ex vivo model for studying glucocorticoid-induced ocular hypertension and glaucoma.
Mao W; Tovar-Vidales T; Yorio T; Wordinger RJ; Clark AF
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8068-75. PubMed ID: 21911581
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid induction of the glaucoma gene MYOC in human and monkey trabecular meshwork cells and tissues.
Clark AF; Steely HT; Dickerson JE; English-Wright S; Stropki K; McCartney MD; Jacobson N; Shepard AR; Clark JI; Matsushima H; Peskind ER; Leverenz JB; Wilkinson CW; Swiderski RE; Fingert JH; Sheffield VC; Stone EM
Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1769-80. PubMed ID: 11431441
[TBL] [Abstract][Full Text] [Related]
3. NFATc1 activity regulates the expression of myocilin induced by dexamethasone.
Faralli JA; Clark RW; Filla MS; Peters DM
Exp Eye Res; 2015 Jan; 130():9-16. PubMed ID: 25450062
[TBL] [Abstract][Full Text] [Related]
4. Ex-vivo cultured human corneoscleral segment model to study the effects of glaucoma factors on trabecular meshwork.
Kasetti RB; Patel PD; Maddineni P; Zode GS
PLoS One; 2020; 15(6):e0232111. PubMed ID: 32579557
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the myocilin (MYOC) glaucoma gene in monkey and human steroid-induced ocular hypertension.
Fingert JH; Clark AF; Craig JE; Alward WL; Snibson GR; McLaughlin M; Tuttle L; Mackey DA; Sheffield VC; Stone EM
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):145-52. PubMed ID: 11133859
[TBL] [Abstract][Full Text] [Related]
6. Effect of topical Ginkgo biloba extract on steroid-induced changes in the trabecular meshwork and intraocular pressure.
Jia LY; Sun L; Fan DS; Lam DS; Pang CP; Yam GH
Arch Ophthalmol; 2008 Dec; 126(12):1700-6. PubMed ID: 19064852
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone-Induced Ocular Hypertension in Mice: Effects of Myocilin and Route of Administration.
Patel GC; Phan TN; Maddineni P; Kasetti RB; Millar JC; Clark AF; Zode GS
Am J Pathol; 2017 Apr; 187(4):713-723. PubMed ID: 28167045
[TBL] [Abstract][Full Text] [Related]
8. Effects of elevated intraocular pressure on outflow facility and TIGR/MYOC expression in perfused human anterior segments.
Borrás T; Rowlette LL; Tamm ER; Gottanka J; Epstein DL
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):33-40. PubMed ID: 11773009
[TBL] [Abstract][Full Text] [Related]
9. Functional delivery of synthetic naked siRNA to the human trabecular meshwork in perfused organ cultures.
Comes N; Borrás T
Mol Vis; 2007 Aug; 13():1363-74. PubMed ID: 17768383
[TBL] [Abstract][Full Text] [Related]
10. Myocilin gene expression in the trabecular meshwork of rats in a steroid-induced ocular hypertension model.
Sawaguchi K; Nakamura Y; Nakamura Y; Sakai H; Sawaguchi S
Ophthalmic Res; 2005; 37(5):235-42. PubMed ID: 16020952
[TBL] [Abstract][Full Text] [Related]
11. Dexamethasone-induced ocular hypertension in perfusion-cultured human eyes.
Clark AF; Wilson K; de Kater AW; Allingham RR; McCartney MD
Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):478-89. PubMed ID: 7843916
[TBL] [Abstract][Full Text] [Related]
12. Reduced myocilin expression in cultured monkey trabecular meshwork cells induced by a selective glucocorticoid receptor agonist: comparison with steroids.
Pfeffer BA; DeWitt CA; Salvador-Silva M; Cavet ME; López FJ; Ward KW
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):437-46. PubMed ID: 19696178
[TBL] [Abstract][Full Text] [Related]
13. Identification of proteomic changes for dexamethasone-induced ocular hypertension using a tandem mass tag (TMT) approach.
Liang X; Li N; Rong Y; Wang J; Zhang H
Exp Eye Res; 2022 Mar; 216():108914. PubMed ID: 34979099
[TBL] [Abstract][Full Text] [Related]
14. Ultrastructural changes associated with dexamethasone-induced ocular hypertension in mice.
Overby DR; Bertrand J; Tektas OY; Boussommier-Calleja A; Schicht M; Ethier CR; Woodward DF; Stamer WD; Lütjen-Drecoll E
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4922-33. PubMed ID: 25028360
[TBL] [Abstract][Full Text] [Related]
15. Differential response and withdrawal profile of glucocorticoid-treated human trabecular meshwork cells.
Li G; Cui G; Dismuke WM; Navarro I; Perkumas K; Woodward DF; Stamer WD
Exp Eye Res; 2017 Feb; 155():38-46. PubMed ID: 27939447
[TBL] [Abstract][Full Text] [Related]
16. Recombinant TIGR/MYOC increases outflow resistance in the human anterior segment.
Fautsch MP; Bahler CK; Jewison DJ; Johnson DH
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4163-8. PubMed ID: 11095610
[TBL] [Abstract][Full Text] [Related]
17. Regulation of glucocorticoid responsiveness in glaucomatous trabecular meshwork cells by glucocorticoid receptor-beta.
Zhang X; Clark AF; Yorio T
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4607-16. PubMed ID: 16303956
[TBL] [Abstract][Full Text] [Related]
18. Effects of glucocorticoids on the trabecular meshwork: towards a better understanding of glaucoma.
Wordinger RJ; Clark AF
Prog Retin Eye Res; 1999 Sep; 18(5):629-67. PubMed ID: 10438153
[TBL] [Abstract][Full Text] [Related]
19. mRNA in situ hybridization of TIGR/MYOC in human trabecular meshwork.
Wang X; Johnson DH
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1724-9. PubMed ID: 10845592
[TBL] [Abstract][Full Text] [Related]
20. Expression of 14-3-3 Zeta Protein in Dexamethasone-Treated Mice and Human TM-1 Cells.
Liu Q; Ye Y; Lin X; Yang Y; Wu K; Yu M
Curr Eye Res; 2017 Aug; 42(8):1124-1129. PubMed ID: 28494163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
